Clinical Trial in China
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT05580952
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 120 participants
- Sponsor
- Genesis Medtech Corporation
- Registry
-
NCT05580952
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05580952. Allocation not applicable; no masking; primary purpose treatment. Start 2022-10-14 (anticipated); primary completion 2023-05-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Trial in China
- Condition
- Diseases of Aortic Valve
- Condition
- Aortic Regurgitation Disease
- Intervention (Device)
- Transcatheter aortic valve replacement
- Lead sponsor
- Genesis Medtech Corporation
Record details
- Record id
cardio:ct-nct05580952- Content hash
688b62aa934538a2c9c20df10423f915fe0aa5dc8339c58c882dcc095f6bdd3e